- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Insomnia Pharmacological Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Insomnia Pharmacological Treatmentmarket, defines the market attractiveness level of Insomnia Pharmacological Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Insomnia Pharmacological Treatment industry, describes the types of Insomnia Pharmacological Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insomnia Pharmacological Treatment market and the development prospects and opportunities of Insomnia Pharmacological Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insomnia Pharmacological Treatment market in Chapter 13.
By Player:
Meda Consumer Healthcare Inc (US)
Takeda Pharmaceutical Company Ltd (Japan)
Sanofi (France)
Merck & Co, Inc (US)
Eisai, Co Ltd (Japan)
Purdue Pharma LP (US)
Pernix Therapeutics (US)
Pfizer, Inc (US)
By Type:
Prescription Sleep Aids
Over-the-Counter Sleep Aids
By End-User:
Homecare
Clinic
Hospital
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Insomnia Pharmacological Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Insomnia Pharmacological Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Insomnia Pharmacological Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Insomnia Pharmacological Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Insomnia Pharmacological Treatment Market Analysis and Outlook to 2022
-
7.1 Global Insomnia Pharmacological Treatment Consumption (2017-2022)
-
7.2 United States Insomnia Pharmacological Treatment Consumption (2017-2022)
-
7.3 Europe Insomnia Pharmacological Treatment Consumption (2017-2022)
-
7.4 China Insomnia Pharmacological Treatment Consumption (2017-2022)
-
7.5 Japan Insomnia Pharmacological Treatment Consumption (2017-2022)
-
7.6 India Insomnia Pharmacological Treatment Consumption (2017-2022)
-
7.7 South Korea Insomnia Pharmacological Treatment Consumption (2017-2022)
8 Region and Country-wise Insomnia Pharmacological Treatment Market Analysis and Outlook to 2028
-
8.1 Global Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)
-
8.2 United States Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)
-
8.4 China Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)
-
8.6 India Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Insomnia Pharmacological Treatment Consumption Forecast (2022-2028)
9 Global Insomnia Pharmacological Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Insomnia Pharmacological Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Prescription Sleep Aids Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Over-the-Counter Sleep Aids Consumption and Growth Rate (2017-2022)
-
9.2 Global Insomnia Pharmacological Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Homecare Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hospital Consumption and Growth Rate (2017-2022)
10 Global Insomnia Pharmacological Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Prescription Sleep Aids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Over-the-Counter Sleep Aids Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Homecare Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
11 Global Insomnia Pharmacological Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Insomnia Pharmacological Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Insomnia Pharmacological Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Insomnia Pharmacological Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Insomnia Pharmacological Treatment Market Competitive Analysis
-
14.1 Meda Consumer Healthcare Inc (US)
-
14.1.1 Meda Consumer Healthcare Inc (US) Company Details
-
14.1.2 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product and Service
-
14.2 Takeda Pharmaceutical Company Ltd (Japan)
-
14.2.1 Takeda Pharmaceutical Company Ltd (Japan) Company Details
-
14.2.2 Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Product and Service
-
14.3 Sanofi (France)
-
14.3.1 Sanofi (France) Company Details
-
14.3.2 Sanofi (France) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi (France) Insomnia Pharmacological Treatment Product and Service
-
14.4 Merck & Co, Inc (US)
-
14.4.1 Merck & Co, Inc (US) Company Details
-
14.4.2 Merck & Co, Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck & Co, Inc (US) Insomnia Pharmacological Treatment Product and Service
-
14.5 Eisai, Co Ltd (Japan)
-
14.5.1 Eisai, Co Ltd (Japan) Company Details
-
14.5.2 Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Product and Service
-
14.6 Purdue Pharma LP (US)
-
14.6.1 Purdue Pharma LP (US) Company Details
-
14.6.2 Purdue Pharma LP (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Purdue Pharma LP (US) Insomnia Pharmacological Treatment Product and Service
-
14.7 Pernix Therapeutics (US)
-
14.7.1 Pernix Therapeutics (US) Company Details
-
14.7.2 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product and Service
-
14.8 Pfizer, Inc (US)
-
14.8.1 Pfizer, Inc (US) Company Details
-
14.8.2 Pfizer, Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Insomnia Pharmacological Treatment
-
Figure Insomnia Pharmacological Treatment Picture
-
Table Global Insomnia Pharmacological Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insomnia Pharmacological Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insomnia Pharmacological Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Insomnia Pharmacological Treatment Consumption by Country (2017-2022)
-
Figure United States Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Insomnia Pharmacological Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Insomnia Pharmacological Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Insomnia Pharmacological Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prescription Sleep Aids Consumption and Growth Rate (2017-2022)
-
Figure Global Over-the-Counter Sleep Aids Consumption and Growth Rate (2017-2022)
-
Figure Global Homecare Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Prescription Sleep Aids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Over-the-Counter Sleep Aids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Homecare Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Insomnia Pharmacological Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Insomnia Pharmacological Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Meda Consumer Healthcare Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product and Service
-
Table Takeda Pharmaceutical Company Ltd (Japan) (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Ltd (Japan) Insomnia Pharmacological Treatment Product and Service
-
Table Sanofi (France) (Foundation Year, Company Profile and etc.)
-
Table Sanofi (France) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi (France) Insomnia Pharmacological Treatment Product and Service
-
Table Merck & Co, Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Merck & Co, Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co, Inc (US) Insomnia Pharmacological Treatment Product and Service
-
Table Eisai, Co Ltd (Japan) (Foundation Year, Company Profile and etc.)
-
Table Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eisai, Co Ltd (Japan) Insomnia Pharmacological Treatment Product and Service
-
Table Purdue Pharma LP (US) (Foundation Year, Company Profile and etc.)
-
Table Purdue Pharma LP (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Purdue Pharma LP (US) Insomnia Pharmacological Treatment Product and Service
-
Table Pernix Therapeutics (US) (Foundation Year, Company Profile and etc.)
-
Table Pernix Therapeutics (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product and Service
-
Table Pfizer, Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Pfizer, Inc (US) Insomnia Pharmacological Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer, Inc (US) Insomnia Pharmacological Treatment Product and Service
-